Aimmune Therapeutics

AIMT

25.66

-0.06

-0.2%

After Hours:

37.30

+11.64

+45.4%

Please Login or Register

Login|Register FREE

Stock Price
Open: 26.03
Prev. Close: 25.72
Low/Hi: 25.45 - 26.03
52-Week: 14.87 - 27.31
Volumes
Equity: 303,045
90-Day Avg: 282,499
Option: 303
90-Day Avg: 302
Volatility
Todays Stock Vol: 28.9
20-Day (HV): 44.4
52-Week (HV): 49.8
30-Day IV: 118.2 +4.1
IV Pct Rank: 100% Elevated
Fundamental
Div. Yield: 0.0%
Earnings: 15-Nov (Est.)
P/E Ratio:
Market Cap: 1.3 B
Stock Type: Common
Sector: Healthcare
Industry: Biotechnology
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

AIMT Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Jun-2017 31-Mar-2017 31-Dec-2016 30-Sep-2016
Cash and Cash Equivalents 84,451 78,714 124,010 76,911
Short Term Investments 152,874 167,533 124,921 73,332
Investments - - - -
Accounts Receivable 0 0 0 0
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 5,287 2,625 2,749 2,338
Net Property Plant and Equipment 13,142 11,147 10,391 9,034
Other Current Assets 0 0 0 0
Current Assets 242,612 248,872 251,680 152,581
Goodwill and Intangibles 0 0 0 0
Long Term Investments 0 13,065 33,602 9,012
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 256,354 276,289 298,789 173,727
Short Term Debt 0 0 0 0
Other Non-Current Assets 600 3,205 3,116 3,100
Accounts Payable 2,310 1,676 1,427 1,470
Accrued Liabilities and Other Payables 15,622 8,440 9,921 10,249
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 19,563 11,571 12,817 13,228
Other Current Liabilities 108 107 102 128
Accumulated Other Comprehensive Income -135 -122 -27 14
Preferred Stock 0 0 0 0
Current Liabilities 18,040 10,223 11,450 11,847
Common Stock 5 5 5 4
Other Non-Current Liabilities 1,523 1,348 1,367 1,381
Additional Paid-In Capital 429,445 424,862 420,151 269,562
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -192,524 -160,027 -134,157 -109,081
Total Equity 236,791 264,718 285,972 160,499
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014
Cash and Cash Equivalents 124,010 76,677 2,269
Short Term Investments 124,921 115,158 0
Investments - - -
Accounts Receivable 0 0 0
Inventory 0 0 0
Loans - - -
Prepaid Expenses 2,749 5,622 106
Net Property Plant and Equipment 10,391 2,702 87
Other Current Assets 0 0 0
Current Assets 251,680 197,457 2,375
Goodwill and Intangibles 0 0 0
Long Term Investments 33,602 7,992 0
Other Assets - - -
Long Term Receivables 0 0 0
Total Assets 298,789 212,361 2,531
Short Term Debt 0 0 0
Other Non-Current Assets 3,116 4,210 69
Accounts Payable 1,427 1,863 478
Accrued Liabilities and Other Payables 9,921 3,118 1,259
Long Term Debt 0 0 0
Other Liabilities - - -
Current Portion of Long Term Debt 0 0 0
Total Liabilities 12,817 6,110 1,860
Other Current Liabilities 102 117 67
Accumulated Other Comprehensive Income -27 -88 0
Preferred Stock 0 0 16,928
Current Liabilities 11,450 5,098 1,804
Common Stock 5 4 0
Other Non-Current Liabilities 1,367 1,012 56
Additional Paid-In Capital 420,151 259,668 1,260
Treasury Stock 0 0 0
Other Equity 0 0 0
Retained Earnings -134,157 -53,333 -17,517
Total Equity 285,972 206,251 671